A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study. [electronic resource]
Producer: 20130207Description: 356-61 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Angiogenic Proteins -- blood
- Biomarkers, Tumor -- blood
- Carcinosarcoma -- blood
- Drug Administration Schedule
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Middle Aged
- Survival Analysis
- Thalidomide -- therapeutic use
- Treatment Outcome
- Uterine Neoplasms -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.